Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis.
Nadav MichaanMoshe LeshnoYoni CohenTamar SafraShira Peleg-HassonIdo LaskovDan GrisaruPublished in: Reproductive biology and endocrinology : RB&E (2021)
IVF/ PGT-M and BRCA negative embryo transfer compared to natural conception among BRCA positive parents is cost effective and may be offered for selected couples with high BRCA mutation related morbidity or mortality. Our results could impact decisions regarding conception among BRCA positive couples and health care providers.